Compare fund portfolios
See how two funds' portfolios overlap. Enter two tickers:
PHSRX vs JDOC
Shared holdings
27
PHSRX covered by JDOC
64.27%
JDOC covered by PHSRX
64.27%
Coverage = share of one portfolio's weight reproduced by the other (overlapping positions, min weight). Top 43 positions per side shown; = held by both — hover a shared position to highlight it in both columns.
PHSRX (Feb. 28, 2026)
| Security | Weight | |
|---|---|---|
| LILLY ELI and CO | 11.32% | |
| JOHNSON&JOHNSON | 8.89% | |
| ABBVIE INC | 5.93% | |
| Novartis AG (Registered) | 5.52% | |
| MERCK & CO | 5.32% | |
| ASTRAZENECA PLC | 5.04% | |
| UNITEDHEALTH GRP | 4.92% | |
| INTUITIVE SURGICAL INC | 3.89% | |
| THERMO FISHER SCIENTIFIC INC | 3.70% | |
| ROCHE HOLDINGS AG (GENUSSCHEINE) | 2.90% | |
| BOSTON SCIENTIFIC CORP | 2.83% | |
| GILEAD SCIENCES INC | 2.68% | |
| MCKESSON CORP | 2.62% | |
| MEDTRONIC PLC | 2.47% | |
| Sanofi SA | 2.33% | |
| VERTEX PHARMACEUTICALS INC | 2.30% | |
| CARDINAL HEALTH INC | 2.27% | |
| BRISTOL-MYERS SQUIBB CO | 2.08% | |
| CVS HEALTH CORP | 1.84% | |
| Ascendis Pharma A/S | 1.67% | |
| EDWARDS LIFESCIENCES CORP | 1.62% | |
| HCA HEALTHCARE INC | 1.52% | |
| NOVO NORDISK-B | 1.45% | |
| Putnam Short Term Investment Fund, Class P | 1.32% | |
| ALNYLAM PHARMACEUTICALS INC | 1.31% | |
| CHUGAI PHARMA CO | 1.25% | |
| HOYA CORP | 1.24% | |
| REGENERON PHARMACEUTICALS INC | 1.23% | |
| UCB SA | 1.04% | |
| ARGENX SE | 1.01% | |
| ABBOTT LABS | 0.99% | |
| BECTON DICKINSON and CO | 0.98% | |
| GSK PLC | 0.95% | |
| VAXCYTE INC | 0.88% | |
| INSMED INC | 0.84% | |
| RHYTHM PHARMACEUTICALS INC | 0.63% | |
| US ULTRA BOND CBT Sep25 | 0.43% | |
| NEWAMSTERDAM PHARMA COMPANY NV | 0.25% | |
| PRECIGEN INC | 0.22% | |
| Putnam Cash Collateral Pool LLC | 0.15% | |
| U.S. Treasury Bills | 0.12% | |
| U.S. Treasury Bills | 0.03% | |
| FX Spot Contract: EUR/USD SETTLE 2026-01-05 | 0.00% |
JDOC (Jan. 31, 2026)
| Security | Weight | |
|---|---|---|
| JOHNSON&JOHNSON | 7.49% | |
| LILLY ELI and CO | 7.26% | |
| ABBVIE INC | 5.46% | |
| MERCK & CO | 5.15% | |
| ASTRAZENECA PLC | 4.80% | |
| NOVO NORDISK-B | 3.68% | |
| UNITEDHEALTH GRP | 3.52% | |
| DANAHER CORP | 3.19% | |
| MEDTRONIC PLC | 3.13% | |
| ROCHE HOLDINGS AG (GENUSSCHEINE) | 2.95% | |
| BRISTOL-MYERS SQUIBB CO | 2.45% | |
| BOSTON SCIENTIFIC CORP | 2.44% | |
| CVS HEALTH CORP | 2.42% | |
| ARGENX SE | 2.37% | |
| MCKESSON CORP | 2.11% | |
| REGENERON PHARMACEUTICALS INC | 2.10% | |
| LONZA GROUP -REG | 1.97% | |
| ESSILORLUXOTTICA | 1.94% | |
| HOYA CORP | 1.93% | |
| UCB SA | 1.90% | |
| VERTEX PHARMACEUTICALS INC | 1.86% | |
| STRYKER CORP | 1.72% | |
| THERMO FISHER SCIENTIFIC INC | 1.69% | |
| CARDINAL HEALTH INC | 1.68% | |
| EDWARDS LIFESCIENCES CORP | 1.66% | |
| IQVIA HOLDINGS INC | 1.44% | |
| INTUITIVE SURGICAL INC | 1.36% | |
| TEVA PHARMACEUTICAL INDUSTRIES LTD | 1.24% | |
| Fresenius SE & Company KGaA | 1.21% | |
| Novartis AG (Registered) | 1.15% | |
| Sartorius Aktiengesellschaft | 1.05% | |
| BIOGEN INC | 0.95% | |
| AXSOME THERAPEUTICS INC | 0.91% | |
| IONIS PHARMACEUTICALS INC | 0.90% | |
| APOGEE THERAPEUTICS INC | 0.84% | |
| NEUROCRINE BIOSCIENCES INC | 0.78% | |
| Ascendis Pharma A/S | 0.77% | |
| GENMAB AS | 0.74% | |
| UNITED THERAPEUTICS CORP DEL | 0.73% | |
| IMMUNOME INC | 0.71% | |
| DISC MEDICINE INC | 0.67% | |
| DAIICHI SANKYO | 0.67% | |
| VIRIDIAN THERAPEUTICS INC | 0.66% | |
| DYNE THERAPEUTICS INC | 0.66% | |
| CG ONCOLOGY INC | 0.63% | |
| CONVATEC GROUP P | 0.59% | |
| REVOLUTION MEDICINES INC | 0.51% | |
| WATERS CORP | 0.49% | |
| CYTOKINETICS INC | 0.49% | |
| BIO-TECHNE CORP | 0.47% |
Machine-readable: JSON · Markdown. Programmatic access via the agent surface.